Pranita Kaphle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pranita Kaphle has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Alice S. Mims
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
11 shared publications - Amy Burd
The Leukemia & Lymphoma Society 10573 Rye Brook NY USA
11 shared publications - Cheng Cameron Yin
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
11 shared publications - Fatma Neslihan Kalkan
Department of Internal Medicine University of Texas Southwestern Medical Center 75390 Dallas TX USA
11 shared publications - Feng Cai
Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA
11 shared publications - Helen Stephens
Department of Internal Medicine University of Texas Southwestern Medical Center 75390 Dallas TX USA
11 shared publications
Latest Publications
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance